📰 Cov Phase News
Page 2 - Cov Phase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cov Phase. Real-time updates on events, politics, business and more.
May 25, 2022
Progressing broad vaccine development program in collaboration with GSK, with second-generation candidates in Phase 1 clinical trials for COVID-19 and influenzaCureVac eligible to a €10 million milestone
May 25, 2022
Investegate announcements from CureVac, CureVac Announces Financial Results for the First Quarter of 2022 and Provides Business Update
May 25, 2022
25.05.2022 - Issuer: CureVac / Key word(s): Quarter Results CureVac Announces Financial Results for the First Quarter of 2022 and Provides Business Update 25.05.2022 / 13:05 The issuer is solely responsible for the content of this announcement. CureVac ...
May 25, 2022
Issuer: CureVac / Key word(s): Quarter Results25.05.2022 / 13:05 The issuer is solely responsible for the content of this announcement.CureVac Announces Financial Results for the First Quarter of 2022 and Provides Business Update Progressing broad vaccine development program in collaboration with GSK, with second-g...
May 25, 2022
DGAP-News: CureVac Announces Financial Results for the First Quarter of 2022 and Provides Business Update
May 4, 2021
CureVac’s unique vaccine properties may be key in delivering mRNA vaccines to developing nations By Globaldata Healthcare 28 Apr 2021 (Last Updated May 4th, 2021 15:48) The rapid development and distribution of highly efficacious messenger ribonucleic acid (mRNA) vaccines has been regarded as a great success, especially during the ongoing pandemic. As COVID-19 cases continue to soar in some countries, demand for Pfizer and Mo...